Ciphergen Biosystems, Inc.
ProteinChip System developer reports financial results for first-quarter 2005
Published in Lab Law Weekly, June 10th, 2005
Ciphergen's total revenue was $6.6 million in the first quarter of 2005 as compared to $13.3 million in the first quarter of 2004. Ciphergen's net loss was $9.3 million in the first quarter of 2005 as compared to $7.5 million in the first quarter of 2004.
At March 31, 2005, the company's cash and investments were $32.2 million. Total long-term debt totaled $28.4 million, of which $28.2 million was convertible debt.
"We have made solid progress in 2005 in our diagnostics division, in particular in optimizing ovarian cancer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2005-06-10)
More Articles from Lab Law Weekly
- GenVault Corp.
Company gets rights to DNA labeling technology - Genitope Corp.
H. David Miller named VP of information technology and legal affairs - Heska Corporation
Diagnostics company announces 200th U.S. patent issued - Hollis-Eden Pharmaceuticals, Inc.
Pharmaceutical firm reports loss of $0.35 per share - LMA International NV
Designer of laryngeal mask files court action for patent infringement in Germany - Linguagen Corp.
Flavor-focused company forms scientific advisory board to further taste research - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
